Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study
详细信息 查看全文
- 作者：Hitoshi Ishii ; Tetsuji Niiya ; Yasuhiro Ono…
- 关键词：Type 2 diabetes mellitus ; T2DM ; GLP ; 1 ; Liraglutide ; Quality of life ; DTR ; QOL
- 刊名：Diabetology & Metabolic Syndrome
- 出版年：2017
- 出版时间：December 2017
- 年：2017
- 卷：9
- 期：1
- 全文大小：1071KB
- 刊物主题：Diabetes; Metabolic Diseases; Endocrinology;
- 出版者：BioMed Central
- ISSN：1758-5996
- 卷排序：9
文摘
BackgroundIn addition to achieving good glycemic control, diabetes care management aims to improve the quality of life (QOL) in patients. Treatment-associated difficulties and side effects frequently cause deterioration in QOL. Liraglutide, a GLP-1 receptor agonist, is a novel injection drug that promotes insulin secretion. It is a user-friendly, once-daily injection with fewer hypoglycemic events. In this study, we aimed to examine the effect of liraglutide therapy on QOL in patients.